Hiroyuki Shimada

30.6k total citations · 5 hit papers
379 papers, 20.8k citations indexed

About

Hiroyuki Shimada is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hiroyuki Shimada has authored 379 papers receiving a total of 20.8k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Neurology, 115 papers in Molecular Biology and 67 papers in Cancer Research. Recurrent topics in Hiroyuki Shimada's work include Neuroblastoma Research and Treatments (163 papers), Cancer, Hypoxia, and Metabolism (49 papers) and Cancer therapeutics and mechanisms (39 papers). Hiroyuki Shimada is often cited by papers focused on Neuroblastoma Research and Treatments (163 papers), Cancer, Hypoxia, and Metabolism (49 papers) and Cancer therapeutics and mechanisms (39 papers). Hiroyuki Shimada collaborates with scholars based in United States, Japan and Canada. Hiroyuki Shimada's co-authors include Robert C. Seeger, Katherine K. Matthay, Robert B. Gerbing, Daniel O. Stram, Yves A. DeClerck, C. Patrick Reynolds, Garrett M. Brodeur, Junichi Hata, Borghild Roald and Louis P. Dehner and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Hiroyuki Shimada

367 papers receiving 20.4k citations

Hit Papers

Treatment of High-Risk Neuroblastoma with Intensive Chem... 1984 2026 1998 2012 1999 1999 1984 2009 2021 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
    1999 1.4k citations Katherine K. Matthay, Robert C. Seeger et al. profile →
  2. The International Neuroblastoma Pathology Classification (the Shimada system)
    1999 739 citations Hiroyuki Shimada, Louis P. Dehner et al. Cancer profile →
  3. Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas
    1984 665 citations Hiroyuki Shimada et al. profile →
  4. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
    2009 621 citations Katherine K. Matthay, C. Patrick Reynolds et al. Journal of Clinical Oncology profile →
  5. Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
    2021 249 citations Shahab Asgharzadeh, Hiroyuki Shimada et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Shimada United States 74 10.4k 8.6k 5.3k 3.9k 2.7k 379 20.8k
John M. Maris United States 83 15.7k 1.5× 13.6k 1.6× 8.4k 1.6× 6.3k 1.6× 2.5k 0.9× 472 26.5k
Robert J. Coffey United States 98 3.5k 0.3× 16.7k 1.9× 6.4k 1.2× 7.8k 2.0× 4.0k 1.5× 416 34.1k
Caterina Giannini United States 76 5.6k 0.5× 5.1k 0.6× 2.5k 0.5× 2.5k 0.6× 5.1k 1.9× 398 19.8k
Ricardo V. Lloyd United States 83 3.3k 0.3× 6.1k 0.7× 2.6k 0.5× 6.2k 1.6× 2.0k 0.8× 529 24.6k
P. O’Connell United States 59 3.8k 0.4× 6.7k 0.8× 2.0k 0.4× 2.3k 0.6× 1.9k 0.7× 248 15.5k
Raf Sciot Belgium 81 3.3k 0.3× 4.6k 0.5× 2.0k 0.4× 5.2k 1.3× 12.5k 4.7× 555 24.8k
Julian Downward United Kingdom 101 2.5k 0.2× 30.1k 3.5× 4.9k 0.9× 11.4k 2.9× 3.1k 1.2× 292 41.7k
Ho‐Keung Ng Hong Kong 52 2.8k 0.3× 5.6k 0.6× 2.9k 0.5× 1.7k 0.4× 2.6k 1.0× 340 16.1k
Daniel J. Brat United States 72 3.4k 0.3× 7.8k 0.9× 4.9k 0.9× 3.6k 0.9× 3.5k 1.3× 312 23.3k
David Zagzag United States 67 2.2k 0.2× 7.8k 0.9× 5.3k 1.0× 3.4k 0.9× 1.7k 0.6× 258 19.3k

Countries citing papers authored by Hiroyuki Shimada

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Shimada more than expected).

Fields of papers citing papers by Hiroyuki Shimada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Shimada. The network helps show where Hiroyuki Shimada may publish in the future.

Co-authorship network of co-authors of Hiroyuki Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Shimada. A scholar is included among the top collaborators of Hiroyuki Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Shimada. Hiroyuki Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiu, Bill, Hiroyuki Shimada, Thomas Hui, et al.. (2024). Differences between male and female patients with pilonidal disease. SHILAP Revista de lepidopterología. 6. 100132–100132. 4 indexed citations
2.
Tamamitsu, Miu, Keiichiro Toda, Venkata Ramaiah Badarla, et al.. (2024). Mid-infrared wide-field nanoscopy. Nature Photonics. 18(7). 738–743. 11 indexed citations
3.
Shimada, Hiroyuki, Jun Takeuchi, Akitoshi Takeda, et al.. (2020). Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International Journal of Molecular Sciences. 21(12). 4443–4443. 9 indexed citations
4.
Wu, Hongwei, Michael A. Sheard, Jemily Malvar, et al.. (2019). Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells. Clinical Cancer Research. 25(15). 4761–4774. 57 indexed citations
5.
Ishida, Yukimasa, Hiromu Fukuda, Ko Fujioka, et al.. (2017). Long‐term changes in recruitment of age‐0 Pacific bluefin tuna (Thunnus orientalis) and environmental conditions around Japan. Fisheries Oceanography. 27(1). 41–48. 9 indexed citations
6.
Borriello, Lucia, Rie Nakata, Michael A. Sheard, et al.. (2017). Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. Cancer Research. 77(18). 5142–5157. 146 indexed citations
7.
8.
Solari, Valeria, Lucia Borriello, Gianluca Turcatel, et al.. (2014). MYCN-Dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival. Cancer Research. 74(21). 5999–6009. 9 indexed citations
9.
Ara, Tasnim, Rie Nakata, Michael A. Sheard, et al.. (2013). Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma. Cancer Research. 73(13). 3852–3864. 105 indexed citations
10.
Silverman, Ayaka M., Rie Nakata, Hiroyuki Shimada, Richard Sposto, & Yves A. DeClerck. (2012). A Galectin-3–Dependent Pathway Upregulates Interleukin-6 in the Microenvironment of Human Neuroblastoma. Cancer Research. 72(9). 2228–2238. 73 indexed citations
11.
Kiyohara, Chikako, Yoshihiro Miyake, Midori Koyanagi, et al.. (2011). Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population. BMC Neurology. 11(1). 89–89. 42 indexed citations
12.
Ji, Lingyun, Hiroyuki Shimada, Michele R. Wing, et al.. (2010). Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 28(12). 1989–1994. 95 indexed citations
13.
Kim, Ji‐Eun, Qiong Wu, Katie M. Wiens, et al.. (2010). PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts. Proceedings of the National Academy of Sciences. 107(40). 17206–17210. 156 indexed citations
14.
Ara, Tasnim, Liping Song, Hiroyuki Shimada, et al.. (2008). Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells. Cancer Research. 69(1). 329–337. 145 indexed citations
15.
Ren, Yue-Xin, Friedrich Graf Finckenstein, Diana Abdueva, et al.. (2008). Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations. Cancer Research. 68(16). 6587–6597. 83 indexed citations
16.
Kang, Hyung‐Gyoo, Nino Keshelava, Hiroyuki Shimada, et al.. (2007). E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase. Cancer Research. 67(7). 3094–3105. 146 indexed citations
17.
18.
Peuchmaur, Michel, Emanuele S. G. d'Amore, Vijay Joshi, et al.. (2003). Revision of the International Neuroblastoma Pathology Classification. Cancer. 98(10). 2274–2281. 173 indexed citations
19.
Goto, Shoko, Robert B. Gerbing, Daniel O. Stram, et al.. (2001). Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. Cancer. 92(10). 2699–2708. 98 indexed citations
20.
Brodeur, Garrett M., A. Thomas Look, Hiroyuki Shimada, et al.. (2001). Biological aspects of neuroblastomas identified by mass screening in quebec. Medical and Pediatric Oncology. 36(1). 157–159. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Maris Breakdown of academic impact, for papers by Robert J. Coffey Breakdown of academic impact, for papers by Caterina Giannini Breakdown of academic impact, for papers by Ricardo V. Lloyd Breakdown of academic impact, for papers by P. O’Connell Breakdown of academic impact, for papers by Raf Sciot Breakdown of academic impact, for papers by Julian Downward Breakdown of academic impact, for papers by Ho‐Keung Ng Breakdown of academic impact, for papers by Daniel J. Brat Breakdown of academic impact, for papers by David Zagzag
Rankless by CCL
2026